Inactive Instrument

Company AEterna Zentaris Inc. Nasdaq

Equities

CA0079753038

Biotechnology & Medical Research

End-of-day quote Nasdaq
- USD - Intraday chart for AEterna Zentaris Inc.

Business Summary

Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). It is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources, which are used in cosmeceutical products, such as oat beta glucan and avenanthramides, and is being developed as potential nutraceuticals and/or pharmaceuticals. Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-1.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Biopharmaceutical
100.0 %
7 100.0 % 6 100.0 % -17.32%

Sales per region

CAD in Million2022Weight2023Weight Delta
Switzerland
96.0 %
7 95.7 % 6 96.0 % -17.04%
Ireland
2.7 %
0 1.5 % 0 2.7 % +54.25%
Other
1.1 %
0 0.1 % 0 1.1 % +1,558.79%
Denmark
0.2 %
0 2.8 % 0 0.2 % -92.87%

Managers

Managers TitleAgeSince
Chief Executive Officer 70 98-12-31
Director of Finance/CFO - 22-01-23
Chief Administrative Officer - 15-09-30
Chief Tech/Sci/R&D Officer - 14-01-31
Chief Tech/Sci/R&D Officer - 03-12-31
Corporate Officer/Principal - 00-12-31
Corporate Officer/Principal - 05-12-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 70 19-12-31
Director/Board Member 62 20-05-14
Director/Board Member - 21-05-04
Chairman - 12-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,061,688 3,012,875 ( 98.41 %) 0 98.41 %

Shareholders

NameEquities%Valuation
Goodwood, Inc.
3.680 %
44,670 3.680 % 432 852 $
41,962 3.457 % 406 612 $
Morgan Stanley Capital Services LLC
0.3332 %
4,045 0.3332 % 39 196 $
Citadel Securities GP LLC
0.3262 %
3,960 0.3262 % 38 372 $
BMO Bank NA (Investment Management)
0.2283 %
2,771 0.2283 % 26 851 $
William Li
0.1975 %
2,397 0.1975 % 23 227 $
1,848 0.1522 % 17 907 $
1,050 0.0865 % 10 175 $
Edmond De Rothschild Holding SA /13F Subfiler/
0.0824 %
1,000 0.0824 % 9 690 $
767 0.0632 % 7 432 $

Company contact information

Æterna Zentaris, Inc.

222 Bay Street Suite 3000

M5K 1E7, Toronto

+

http://www.zentaris.com
address AEterna Zentaris Inc.
  1. Stock Market
  2. Equities
  3. AEZS Stock
  4. Stock
  5. Company AEterna Zentaris Inc.